Panel to examine if nutraceuticals can be produced within drug unit

In a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of nutraceuticals within drug manufacturing facilities in India. This decision comes after the country's drug regulator had previously warned of taking action against those violating regulations by producing supplements and drugs in the same facility.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GjD6iwr
via IFTTT